{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:21:03Z","timestamp":1791231663564,"version":"4.1.0"},"reference-count":41,"publisher":"Japanese Circulation Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2020,9,25]]},"DOI":"10.1253\/circj.cj-19-1165","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T18:06:22Z","timestamp":1598897182000},"page":"1786-1796","source":"Crossref","is-referenced-by-count":35,"title":["Current Trends in Epidemiology and Clinical Features of Thromboangiitis Obliterans in Japan\u3000\u2015 A Nationwide Survey Using the Medical Support System Database \u2015"],"prefix":"10.1253","volume":"84","author":[{"given":"Yoshiko","family":"Watanabe","sequence":"first","affiliation":[{"name":"First Department of Physiology, Kawasaki Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Miyata","sequence":"additional","affiliation":[{"name":"Vascular Center, Sanno Hospital and Sanno Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Shigematsu","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, International University of Health and Welfare, Mita Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Tanemoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Kawasaki Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Nakaoka","sequence":"additional","affiliation":[{"name":"Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Harigai","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Tokyo Women\u2019s Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis (JPVAS)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","unstructured":"1. Malecki R, Kluz J, Przezdziecka-Dolyk J, Adamiec R. The pathogenesis and diagnosis of thromboangiitis obliterans: Is it still a mystery? <i>Adv Clin Exp Med<\/i> 2015; 24: 1085\u20131097."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mills JL Sr. Buerger\u2019s disease in the 21st century: Diagnosis, clinical features, and therapy. <i>Semin Vasc Surg<\/i> 2003; 16: 179\u2013189.","DOI":"10.1016\/S0895-7967(03)00023-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Olin JW. Thromboangiitis obliterans (Buerger\u2019s disease). <i>N Engl J Med<\/i> 2000; 343: 864\u2013869.","DOI":"10.1056\/NEJM200009213431207"},{"key":"4","unstructured":"4. Shionoya S, Ban I, Nakata Y, Matsubara J, Shinjo K. Diagnosis, pathology, and treatment of Buerger\u2019s disease. <i>Surgery<\/i> 1974; 75: 695\u2013700."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sasaki S, Sakuma M, Yasuda K. Current status of thromboangiitis obliterans (Buerger\u2019s disease) in Japan. <i>Int J Cardiol<\/i> 2000; 75(Suppl 1): S175\u2013S181.","DOI":"10.1016\/S0167-5273(00)00190-X"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Papa MZ, Rabi I, Adar R. A point scoring system for the clinical diagnosis of Buerger\u2019s disease. <i>Eur J Vasc Endovasc Surg<\/i> 1996; 11: 335\u2013339.","DOI":"10.1016\/S1078-5884(96)80081-5"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lazarides MK, Georgiadis GS, Papas TT, Nikolopoulos ES. Diagnostic criteria and treatment of Buerger\u2019s disease: A review. <i>Int J Low Extrem Wounds<\/i> 2006; 5: 89\u201395.","DOI":"10.1177\/1534734606288817"},{"key":"8","unstructured":"8. Mills JL, Porter JM. Buerger\u2019s disease: A review and update. <i>Semin Vasc Surg<\/i> 1993; 6: 14\u201323."},{"key":"9","unstructured":"9. Olin JW, Young JR, Graor RA, Ruschhaupt WF, Bartholomew JR. The changing clinical spectrum of thromboangiitis obliterans (Buerger\u2019s disease). <i>Circulation<\/i> 1990; 82: IV3\u2013IV8."},{"key":"10","unstructured":"10. Shionoya S. What is Buerger\u2019s disease? <i>World J Surg<\/i> 1983; 7: 544\u2013551."},{"key":"11","unstructured":"11. The database of the Number of Recipient Certificates Issued for Specific Disease Treatment, Japan Intractable Disease Information Center. http:\/\/www.nanbyou.or.jp\/entry\/1356 (accessed 17 April 2019)."},{"key":"12","unstructured":"12. The Portal site for Japanese Government Statistics (e-Stat). Demographics of Japan 2000\u201315 (updated 28 June 2017). https:\/\/www.e-stat.go.jp\/stat-search\/files?page=1&amp;layout=datalist&amp;toukei=00200524&amp;tstat=000000090001&amp;cycle=0&amp;tclass1=000000090004&amp;tclass2=000001051180&amp;second2=1 (accessed 17 April 2019)."},{"key":"13","unstructured":"13. Summary of patient survey. Japan Ministry of Health, Labor and Welfare; Portal site for Japanese Government Statistics [e-Stat]: 2008. https:\/\/www.e-stat.go.jp\/dbview?sid=0003027500 (accessed 09 July 2019)."},{"key":"14","unstructured":"14. Summary of patient survey. Japan Ministry of Health, Labor and Welfare; Portal site for Japanese Government Statistics [e-Stat]: 2011. https:\/\/www.e-stat.go.jp\/dbview?sid=0003071774 (accessed 09 July 2019)."},{"key":"15","unstructured":"15. Summary of patient survey. Japan Ministry of Health, Labor and Welfare; Portal site for Japanese Government Statistics [e-Stat]: 2014. https:\/\/www.e-stat.go.jp\/dbview?sid=0003128823 (accessed 09 July 2019]."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sun XL, Law BY, de Seabra Rodrigues Dias IR, Mok SWF, He YZ, Wong VK. Pathogenesis of thromboangiitis obliterans: Gene polymorphism and immunoregulation of human vascular endothelial cells. <i>Atherosclerosis<\/i> 2017; 265: 258\u2013265.","DOI":"10.1016\/j.atherosclerosis.2017.08.009"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Mills JL, Porter JM. Buerger\u2019s disease (thromboangiitis obliterans). <i>Ann Vasc Surg<\/i> 1991; 5: 570\u2013572.","DOI":"10.1007\/BF02015288"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Goodman RM, Elian B, Mozes M, Deutsch V. Buerger\u2019s disease in Israel. <i>Am J Med<\/i> 1965; 39: 601\u2013615.","DOI":"10.1016\/0002-9343(65)90083-5"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lie JT. Thromboangiitis obliterans (Buerger\u2019s disease) in women. <i>Medicine (Baltimore)<\/i> 1987; 66: 65\u201372.","DOI":"10.1097\/00005792-198701000-00002"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Wysokinski WE, Kwiatkowska W, Sapian-Raczkowska B, Czarnacki M, Doskocz R, Kowal-Gierczak B. Sustained classic clinical spectrum of thromboangiitis obliterans (Buerger\u2019s disease). <i>Angiology<\/i> 2000; 51: 141\u2013150.","DOI":"10.1177\/000331970005100207"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Zheng JF, Chen YM, Chen DY, Lin CH, Chen HH. The incidence and prevalence of thromboangiitis obliterans in Taiwan: A nationwide, population-based analysis of data collected from 2002 to 2011. <i>Clinics (Sao Paulo, Brazil)<\/i> 2016; 71: 399\u2013403.","DOI":"10.6061\/clinics\/2016(07)08"},{"key":"22","unstructured":"22. Japan Ministry of Health, Labour, and Welfare. 2016 National health and nutrition survey in Japan. 21 September 2017. https:\/\/www.mhlw.go.jp\/file\/04-Houdouhappyou-10904750-Kenkoukyoku-Gantaisakukenkouzoushinka\/kekkagaiyou_7.pdf (accessed 17 April 2019)."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ohta T, Ishioashi H, Hosaka M, Sugimoto I. Clinical and social consequences of Buerger disease. <i>J Vasc Surg<\/i> 2004; 39: 176\u2013180.","DOI":"10.1016\/j.jvs.2003.08.006"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kobayashi M, Nishikimi N, Komori K. Current pathological and clinical aspects of Buerger\u2019s disease in Japan. <i>Ann Vasc Surg<\/i> 2006; 20: 148\u2013156.","DOI":"10.1007\/s10016-005-9436-2"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Laohapensang K, Rerkasem K, Kattipattanapong V. Decrease in the incidence of Buerger\u2019s disease recurrence in northern Thailand. <i>Surg Today<\/i> 2005; 35: 1060\u20131065.","DOI":"10.1007\/s00595-005-3081-9"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Adar R. Epidemiology of TAO: Correction of an error. <i>Atherosclerosis<\/i> 2010; 211: 24.","DOI":"10.1016\/j.atherosclerosis.2010.01.027"},{"key":"27","unstructured":"27. Sekhar S, Thomas D, Meera N, Koneri R, Balakrishna P. Progress and incidence of Buerger\u2019s Disease in Bangalore. <i>Int J Epidemiol<\/i> https:\/\/print.ispub.com\/api\/0\/ispub-article\/8933 (accessed 14 November 2019)."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Le Joncour A, Soudet S, Dupont A, Espitia O, Koskas F, Cluzel P, et al. Long-term outcome and prognostic factors of complications in thromboangiitis obliterans (Buerger\u2019s disease): A multicenter study of 224 patients. <i>J Am Heart Assoc<\/i> 2018; 7: e010677.","DOI":"10.1161\/JAHA.118.010677"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Adar R, Papa MZ, Schneiderman J. Thromboangiitis obliterans: An old disease in need of a new look. <i>Int J Cardio<\/i> 2000; 75(Suppl 1): S167\u2013S170; discussion S171\u2013S173.","DOI":"10.1016\/S0167-5273(00)00185-6"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Shionoya S. Buerger\u2019s disease: Diagnosis and management. <i>Cardiovasc Surg<\/i> 1993; 1: 207\u2013214.","DOI":"10.1177\/096721099300100302"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Hong YM. Atherosclerotic cardiovascular disease beginning in childhood. <i>Korean Circ J<\/i> 2010; 40: 1\u20139.","DOI":"10.4070\/kcj.2010.40.1.1"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. Koskinen J, Magnussen CG, Sinaiko A, Woo J, Urbina E, Jacobs DR Jr, et al. Childhood age and associations between childhood metabolic syndrome and adult risk for metabolic syndrome, type 2 diabetes mellitus and carotid intima media thickness: The International Childhood Cardiovascular Cohort Consortium. <i>J Am Heart Assoc<\/i>, doi:10.1161\/jaha.117.005632 (accessed 17 April 2019).","DOI":"10.1161\/JAHA.117.005632"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Chen Z, Takahashi M, Naruse T, Nakajima T, Chen YW, Inoue Y, et al. Synergistic contribution of CD14 and HLA loci in the susceptibility to Buerger disease. <i>Hum Genet<\/i> 2007; 122: 367\u2013372.","DOI":"10.1007\/s00439-007-0408-1"},{"key":"34","unstructured":"34. Iwai T, Umeda M, Inoue Y. Are there any objections against our hypothesis that Buerger disease is an infectious disease? <i>Ann Vasc Dis<\/i> 2012; 5: 300\u2013309."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Kobayashi M, Sugimoto M, Komori K. Endarteritis obliterans in the pathogenesis of Buerger\u2019s disease from the pathological and immunohistochemical points of view. <i>Circ J<\/i> 2014; 78: 2819\u20132826.","DOI":"10.1253\/circj.CJ-14-0656"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Pavlic V, Vujic-Aleksic V, Zubovic N, Gojkov-Vukelic M. Periodontitis and Buerger\u2019s disease: Recent advances. <i>Acta Inform Med<\/i> 2013; 21: 250\u2013252.","DOI":"10.5455\/aim.2013.21.250-252"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Shi ZF, Fang QB, Limu S, Jiareke T, Ge XH. Association between three SNPs and thromboangiitis obliterans in Xinjiang Uyghur Population. <i>Genet Test Mol Biomarkers<\/i> 2016; 20: 55\u201362.","DOI":"10.1089\/gtmb.2015.0264"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Kurata A, Franke FE, Machinami R, Schulz A. Thromboangiitis obliterans: Classic and new morphological features. <i>Virchows Arch<\/i> 2000; 436: 59\u201367.","DOI":"10.1007\/PL00008199"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Kurata A, Machinami R, Schulz A, Fukayama M, Franke FE. Different immunophenotypes in Buerger\u2019s disease. <i>Pathol Int<\/i> 2003; 53: 608\u2013615.","DOI":"10.1046\/j.1440-1827.2003.01528.x"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Shionoya S. Diagnostic criteria of Buerger\u2019s disease. <i>Int J Cardiol<\/i> 1998; 66(Suppl 1): S243\u2013S245; discussion S247.","DOI":"10.1016\/S0167-5273(98)00175-2"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Igari K, Inoue Y, Iwai T. The epidemiologic and clinical findings of patients with Buerger disease. <i>Ann Vasc Surg<\/i> 2016; 30: 263\u2013269.","DOI":"10.1016\/j.avsg.2015.07.014"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/84\/10\/84_CJ-19-1165\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T19:43:48Z","timestamp":1668195828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/84\/10\/84_CJ-19-1165\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,25]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-19-1165","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,25]]}}}